| Title： | Expert Consensus on RCM Features of Common Melanocytic Skin Tumors |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis |
| Countries and regions： | China |
| Guidelines users： | All dermatologists and dermatological imaging professionals in various medical and healthcare institutions at all levels who perform RCM examinations for patients. |
| Evidence classification method： | With reference to the Oxford Centre for Evidence-Based Medicine (OCEBM) evidence grading system, the supporting evidence for the recommendation is graded accordingly. 1a: Systematic review based on RCTs (high homogeneity) 1b: Individual RCT study 2a: Systematic evaluation based on cohort studies (high homogeneity) 2b: Individual cohort study and low-quality RCT study 3a: Systematic evaluation based on case-control studies (high homogeneity) 3b: Individual case-control study 4: Case report, low-quality cohort/case-control study 5: Expert opinion |
| Development unit： | China Dermatologist Association |
| Registration time: | 2024-04-29 |
| Registration number： | PREPARE-2024CN599 |
| Purpose of the guideline: | The aim is to improve the accuracy and consistency of RCM image interpretation, increase the early detection rate of cutaneous melanocytic tumors, reduce the risk of misdiagnosis and missed diagnosis, and promote reliable and standardized application of RCM in the diagnosis and treatment of cutaneous melanocytic tumors. |
